Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > GKOS Glaukos > Detailed Quotes

GKOS Glaukos

53.240
-0.290-0.54%
Close 09/30 16:00 ET
53.2400.0000.00%
Post Mkt Price 09/30 16:06 ET
High
55.920
Open
53.600
Turnover
26.28M
Low
53.230
Pre Close
53.530
Volume
483.79K
Market Cap
2.53B
P/E(TTM)
Loss
52wk High
64.490
Shares
47.60M
P/E(Static)
Loss
52wk Low
33.330
Float Cap
2.44B
Bid/Ask %
0.00%
Historical High
99.000
Shs Float
45.87M
Volume Ratio
1.16
Historical Low
14.250
Dividend TTM
--
Div Yield TTM
--
P/B
4.50
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.06%
Amplitude
5.03%
Avg Price
54.321
Lot Size
1
Float Cap
2.44B
Bid/Ask %
0.00%
Historical High
99.000
Shs Float
45.87M
Volume Ratio
1.16
Historical Low
14.250
Dividend TTM
--
P/B
4.50
Dividend LFY
--
Turnover Ratio
1.06%
Amplitude
5.03%
Avg Price
54.321
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in San Clemente, CA.
CEO: Mr. Thomas W. Burns
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...